Industry News

Medlab Middle East to Return as Standalone Event in 2023

By Labmedica International staff writers
11 Jan 2022

Illustration

Informa Markets (London, UK), organizers of Medlab Middle East, have announced that the MENA region’s leading exhibition for the laboratory industry will return to a standalone event in 2023.


This announcement follows unprecedented demand from exhibitors and visitors for the 2022 edition of the show, which takes place at the Dubai World Trade Centre from 24-27 January 2022. As a result of the pandemic, Medlab Middle East and Arab Health co-located in 2021 to provide a platform for both the laboratory and general healthcare industries to come together, reconnect and do business face-to-face in a safe and secure environment. However, following high-level demand from leading laboratory companies to showcase their offering in a dedicated space, and from attendees keen to capitalize on the latest laboratory releases, the event will now revert to a standalone format, with dates confirmed for 7-9 February 2023.


The 2022 edition of Medlab Middle East is expected to welcome more than 400 exhibitors, a 100% increase from 2021. Key players participating in this edition include Roche, Siemens, Beckman Coulter, Abbott, Biomerieux and Mindray. In addition to the growth in exhibitors, which is expected to increase to over 500 in 2023, country pavilions have risen from nine in 2021 to 10 in 2022, with that figure expected to increase to 14 in 2023.


Fueling the surge in exhibitors is the anticipated growth in the global laboratory industry. According to the Global Clinical Laboratory Market – Analysis by test, end-user, by region, by country (2021 edition), the global laboratory market is expected to grow by a Compound Annual Growth Rate (CAGR) of 6% between 2021 and 2026, which puts the predicted value of the global laboratory market at US$ 33.07 billion by 2026. The report attributed the growth rate to the increasing number of lifestyle-related ailments and chronic illnesses, and spurts of infectious diseases in different parts of the world. The introduction of accurate and technologically advanced products, such as companion diagnostics, biochips, and microarrays, has bolstered the demand for early disease detection. Moreover, rapid technological advancements to enhance productivity and reduce costs are anticipated to boost the market further. These solutions offer clinicians maximum efficiency and minimum risk of errors, which has driven the uptake of services in the market.


“Advances in the medical laboratory have been pivotal in the defense against the continued threat that COVID-19 poses to industries around the world,” said Tom Coleman, Exhibition Director of Medlab Middle East. “Due to the speed at which the laboratory industry has responded to these threats by developing solutions, products and technology to counter the impact of the pandemic, we have seen a surge in companies wanting to showcase their latest innovations and from buyers eager to capitalize on these advances.”


“As a result of this demand, following the 2022 edition of the show, which will be held from 24 -27 January, Medlab Middle East will return as a standalone event in 2023 with a total of six halls, showcasing the latest innovations and new technologies being utilized in the laboratory industry,” added Coleman.


Related Links:
Informa Markets 



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

20 May 2022
Qiagen Acquires Enzymes Provider Blirt to Strengthen Sample Technologies Business
QIAGEN N.V. (Venlo, Netherlands) has signed agreements to acquire a 96% majority ownership stake in BLIRT S.A. (Gdansk, Poland), a manufacturer of recombinant enzymes for the life science industry.
Read More
16 May 2022
Medtronic Completes Acquisition of Intersect ENT to Add Innovative Sinus Implants to ENT Portfolio
Medtronic plc (Dublin, Ireland) has completed the acquisition of Intersect ENT (Menlo Park, CA, USA), thereby expanding the company's comprehensive ear, nose, and throat (ENT) portfolio with innovative products used in sinus procedures to improve post-operative outcomes and to treat nasal polyps.
Read More
12 May 2022
Global Lateral Flow Assays Market to Surpass USD 11.5 Billion by 2032 Due to Evolving Applications
The global lateral flow assays market is projected to register a CAGR of 4.7% during 2022-2032 to surpass USD 11.7 billion by the end of 2032, driven by the growing prevalence of influenza, STDs, and tuberculosis worldwide and rising awareness among people about the availability of POCT kits.
Read More
11 May 2022
Global Rapid Test Kits Market Driven by Immunoassay and Chromatography-Based Tests
The global rapid test kits market size was valued at more than USD 25.50 billion in 2021 and is expected to register a CAGR of 8.1% over the 2019-2030 period to surpass USD 52 billion in 2030, driven primarily by the increasing prevalence of various infectious diseases.
Read More
03 May 2022
Meridian Acquires Euprotein to Further Expand Recombinant Protein Capabilities
Meridian Bioscience, Inc. (Cincinnati, OH, USA) has acquired, through its subsidiary Meridian Life Science, Inc., substantially all of the assets of EUPROTEIN Inc. (North Brunswick Township, NJ, USA).
Read More
02 May 2022
Globe Scientific Acquired by L Squared Capital Partners
Globe Scientific (Mahwah, NJ, USA), a provider of laboratory consumable supplies, has been acquired by L Squared Capital Partners (Newport Beach, CA, USA), marking its third acquisition as part of GSI Group Holdings.
Read More
29 Apr 2022
GE Healthcare and Medtronic Collaborate to Improve Product Access for ASCs and OBLs
GE Healthcare (Chicago, IL, USA) and Medtronic (Doral, FL, USA) have entered into a collaboration focused on the unique needs and demand for care at Ambulatory Surgery Centers (ASCs) and Office Based Labs (OBLs) that will allow customers to access extensive product portfolios, financial solutions, and exceptional service.
Read More
22 Apr 2022
Global Diagnostic Imaging Market to Surpass USD 33 Billion by 2026
The global diagnostic imaging market is projected to grow at a CAGR of 4.9% from an estimated USD 27.5 billion in 2022 to over USD 33 billion by 2026, driven by technological advancements, favorable demographic factors in the developed regions, growing access to healthcare and rising income levels of the middle class population in the developing regions.
Read More
22 Apr 2022
Global Electrosurgery Market to Reach Almost USD 6 Billion by 2026
The global electrosurgery market is projected to grow at a CAGR of 3.6% from an estimated USD 5 billion in 2022 to almost USD 6 billion by 2026, driven by the rapidly rising number of surgeries being performed globally, an aging population, and increasing prevalence of various chronic diseases.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions